About
Mantle Therapeutics develops treatments for rare neurological diseases by repurposing already approved drugs using AI-driven target assessment, initially focusing on Friedreich’s Ataxia.
Explore Mantle Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.